title: Racial disparities in incidence and outcome in multiple myeloma: a population-based study.
abstract: Multiple myeloma (MM) is the most common hematologic malignancy in blacks. Some prior studies suggest inferior survival in blacks; others suggest similar survival. Using the original 9 Surveillance, Epidemiology, and End Results registries, we conducted a large-scale population-based study including 5798 black and 28 939 white MM patients diagnosed 1973-2005, followed through 2006. Age-adjusted incidence rates, disease-specific survival, and relative survival rates were calculated by race, age, and time period of diagnosis. Mean age at diagnosis was 65.8 and 69.8 years for blacks and whites, respectively (P < .001). Incidence among blacks was m twice that among whites; this disparity was greater among patients < 50 years (P = .002). Over the entire study period, disease-specific and relative survival rates were higher in blacks than whites (P < .001). For whites, 5-year relative survival rates increased significantly 1973-1993 to 1994-1998 (26.3% to 30.8%; P < .001) and 1994-1998 to 1999-2005 (30.8% to 35.0%; P = .004). Survival improvements among blacks were smaller and nonsignificant (1973-1993 to 1999-2005: 31.0% to 34.1%; P = .07). We found (1) a younger age of onset among blacks; (2) better survival in blacks 1973-2005; and (3) significant survival improvement among whites over time, with smaller, nonsignificant change seen among blacks, possibly due to unequal access to and/or disparate responsiveness to novel therapies.
authors.affiliation: National Cancer Institute, Bethesda, MD, USA.
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Waxman
authors.forename: Pamela J
authors.initials: PJ
authors.lastname: Mink
authors.forename: Susan S
authors.initials: SS
authors.lastname: Devesa
authors.forename: William F
authors.initials: WF
authors.lastname: Anderson
authors.forename: Brendan M
authors.initials: BM
authors.lastname: Weiss
authors.forename: Sigurdur Y
authors.initials: SY
authors.lastname: Kristinsson
authors.forename: Katherine A
authors.initials: KA
authors.lastname: McGlynn
authors.forename: Ola
authors.initials: O
authors.lastname: Landgren
mesh_terms: D000367:Age Factors; D000368:Aged; D044383:Black People / Q000706:statistics & numerical data*; D005260:Female; D054625:Healthcare Disparities / Q000706:statistics & numerical data*; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000208:ethnology* / Q000628:therapy; D018426:SEER Program; D015996:Survival Rate; D016896:Treatment Outcome; D044465:White People / Q000706:statistics & numerical data*
references.citation: Br J Haematol. 2003 Jun;121(5):749-57
references.pmid: 12780789
references.citation: Blood. 2006 Sep 15;108(6):2020-8
references.pmid: 16728703
references.citation: J Clin Oncol. 1996 Mar;14(3):974-7
references.pmid: 8622048
references.citation: N Engl J Med. 2003 Dec 25;349(26):2495-502
references.pmid: 14695409
references.citation: Lancet. 1998 Mar 28;351(9107):934-9
references.pmid: 9734939
references.citation: N Engl J Med. 2009 Jun 18;360(25):2645-54
references.pmid: 19535803
references.citation: Am J Med. 1978 May;64(5):814-26
references.pmid: 645746
references.citation: Am J Epidemiol. 1995 Feb 15;141(4):300-4
references.pmid: 7840107
references.citation: Cancer Causes Control. 2006 Sep;17(7):931-8
references.pmid: 16841260
references.citation: J Clin Oncol. 2002 Nov 1;20(21):4319-23
references.pmid: 12409330
references.citation: N Engl J Med. 1980 Jun 12;302(24):1347-9
references.pmid: 7374679
references.citation: Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1117-21
references.pmid: 10613347
references.citation: N Engl J Med. 2006 Mar 30;354(13):1362-9
references.pmid: 16571879
references.citation: N Engl J Med. 1996 Jul 11;335(2):91-7
references.pmid: 8649495
references.citation: Cancer. 1989 Mar 1;63(5):982-7
references.pmid: 2914303
references.citation: Blood. 2006 Feb 1;107(3):904-6
references.pmid: 16210333
references.citation: Blood. 2008 Mar 1;111(5):2516-20
references.pmid: 17975015
references.citation: Blood. 2009 May 28;113(22):5412-7
references.pmid: 19179464
references.citation: N Engl J Med. 2003 Jun 26;348(26):2609-17
references.pmid: 12826635
references.citation: N Engl J Med. 2007 Nov 22;357(21):2123-32
references.pmid: 18032762
references.citation: Blood. 1994 Aug 1;84(3):950-6
references.pmid: 7913845
references.citation: Haematologica. 2006 Oct;91(10):1410-3
references.pmid: 16963396
references.citation: Am J Hematol. 2008 May;83(5):355-8
references.pmid: 18186525
references.citation: JAMA. 1969 Jun 2;208(9):1680-5
references.pmid: 5818682
references.citation: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references.pmid: 19474385
references.citation: J Natl Med Assoc. 2006 Nov;98(11):1860-1
references.pmid: 17128699
references.citation: Blood. 2008 Mar 1;111(5):2521-6
references.pmid: 17901246
references.citation: N Engl J Med. 2008 Aug 28;359(9):906-17
references.pmid: 18753647
references.citation: Mayo Clin Proc. 2007 Dec;82(12):1468-73
references.pmid: 18053453
references.citation: Blood. 2009 May 28;113(22):5418-22
references.pmid: 19234139
references.citation: N Engl J Med. 2004 Oct 28;351(18):1860-73
references.pmid: 15509819
references.citation: J Clin Oncol. 2001 Jan 1;19(1):18-27
references.pmid: 11134191
references.citation: Biometrics. 1983 Dec;39(4):941-8
references.pmid: 6671129
references.citation: Am J Clin Oncol. 2007 Oct;30(5):540-8
references.pmid: 17921717
references.citation: Lancet Oncol. 2010 Jan;11(1):29-37
references.pmid: 19853510
references.citation: Blood. 2009 Jul 23;114(4):791-5
references.pmid: 19182202
references.citation: J Clin Oncol. 2007 May 20;25(15):1993-9
references.pmid: 17420512
references.citation: J Natl Cancer Inst. 2009 Dec 2;101(23):1610
references.pmid: 19910557
references.citation: N Engl J Med. 1999 Nov 18;341(21):1565-71
references.pmid: 10564685
references.citation: Biol Blood Marrow Transplant. 2010 Mar;16(3):395-402
references.pmid: 19922808
references.citation: Cancer. 1984 Dec 15;54(12):3085-94
references.pmid: 6498786
references.citation: J Clin Oncol. 2010 Feb 10;28(5):830-4
references.pmid: 20038719
references.citation: JAMA. 2002 Apr 24;287(16):2106-13
references.pmid: 11966385
references.citation: Int J Cancer. 2009 Nov 1;125(9):2147-50
references.pmid: 19582882
references.citation: Cancer Metastasis Rev. 2003 Mar;22(1):87-93
references.pmid: 12716040